| CYHB2300580 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-03-21 | | | | | view |
| CXHB1100227 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs | Supplementary Application | 2011-12-26 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2012-09-25 | view |
| CYHB2100147 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2021-01-21 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | In Review | 2022-01-19 | view |
| CXHL0900179 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2009-06-09 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2010-02-26 | view |
| CXHL1900044 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | New Drug Application | 2019-03-05 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | In Review | 2019-03-04 | view |
| CXHB1100067 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs | Supplementary Application | 2011-04-06 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2011-09-22 | view |
| CXHS2000028 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | New Drug Application | 2020-09-19 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | In Review | 2020-09-17 | view |
| CYHB2300581 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-03-21 | | | | | view |
| CXHL2000014 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | New Drug Application | 2020-01-16 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | In Review | 2020-01-15 | view |
| CXHB1500023 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs | Supplementary Application | 2015-03-07 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2015-08-11 | view |
| CYHB2300047 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-01-07 | | | | | view |
| CXHS1900034 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | New Drug Application | 2019-11-13 | 和记黄埔医药（苏州）有限公司 | Hutchison Whampoa Pharmaceutical (Suzhou) Co Ltd | Certificate Issued | 2021-01-08 | view |
| CXHL2400018 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(2.4) | New Drug Application | 2024-01-05 | | Hutchison MediPharma Co Ltd | | | view |
| CXHB1500022 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs | Supplementary Application | 2015-03-07 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2015-08-11 | view |
| CYHB2300048 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1) | Supplementary Application | 2023-01-07 | | | | | view |
| CXHL0900180 | 索凡替尼胶囊 | surufatinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2009-06-09 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2010-02-26 | view |
| CXHB1500021 | 索凡替尼 | surufatinib | Active ingredient | Chemical Drugs | Supplementary Application | 2015-03-07 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2015-08-11 | view |
| CXHL0900178 | 索凡替尼 | surufatinib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2009-06-09 | 和记黄埔医药（上海）有限公司 | Hutchison MediPharma Co Ltd | Certificate Issued | 2010-02-26 | view |
